BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10392434)

  • 1. [Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents].
    Boreko EI; Pavlova NI; Votiakov VI
    Vopr Virusol; 1999; 44(3):115-9. PubMed ID: 10392434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiviral action of sodium selenite and its combination with remantadine].
    Abdullaev II; Sycheva IV; Lazymova ZA; Veselovskaia TV; Abdullaev FI
    Vopr Virusol; 1987; 32(6):670-5. PubMed ID: 3445584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of activity against influenza viruses by combinations of antiviral agents.
    Hayden FG; Douglas RG; Simons R
    Antimicrob Agents Chemother; 1980 Oct; 18(4):536-41. PubMed ID: 7447417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity to remantadine and ribavirin of influenza A virus resistant to 2-(1'-aminoethyl)-bicyclo(2.2.1)heptane hydrochloride].
    Gribkova NV; Kazak NF; Votiakov VI
    Vopr Virusol; 1984; 29(5):619-21. PubMed ID: 6516328
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.
    Hayden FG; Schlepushkin AN; Pushkarskaya NL
    Antimicrob Agents Chemother; 1984 Jan; 25(1):53-7. PubMed ID: 6703684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque inhibition assay for drug susceptibility testing of influenza viruses.
    Hayden FG; Cote KM; Douglas RG
    Antimicrob Agents Chemother; 1980 May; 17(5):865-70. PubMed ID: 7396473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bis-(N,N'-uracil-1-yl)-selenoxomethane: an inhibitor of the influenza virus].
    Lazymova ZA; Asadullaev TA; Mamedov ESh; Akhverdieva RIa
    Vopr Virusol; 1988; 33(2):163-5. PubMed ID: 3414065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antiinfluenza activity of a plant preparation SHS-174 and amantadine derivatives.
    Serkedjieva J; Zgorniak-Nowosielska I
    Acta Virol; 1993 Aug; 37(4):258-64. PubMed ID: 7905240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)].
    Pushkarskaia NL; L'vov ND; Galegov GA
    Vopr Virusol; 1980; (3):303-6. PubMed ID: 7434722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of remantadine, ribavirin and their combinations on the protein synthesis of influenza virus A in a cell culture].
    L'vov ND; Pushkarskaia NL; Galegov GA
    Vopr Med Khim; 1981; 27(6):820-3. PubMed ID: 7336658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined action of ribovirin and rimantadine in experimental myxovirus infection.
    Galegov GA; Pushkarskaya NL; Obrosova-Serova NP; Zhdanov VM
    Experientia; 1977 Jul; 33(7):905-6. PubMed ID: 891769
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid method for the detection of synergism in combinations of antiviral substances.
    Rada B; Hanusovská T
    Acta Virol; 1987 Mar; 31(2):126-37. PubMed ID: 2886021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-influenza virus activity of the compound LY253963.
    Hayden FG; Rollins BS; Hay AJ
    Antiviral Res; 1990 Jul; 14(1):25-38. PubMed ID: 2080866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
    Reina J
    Rev Esp Quimioter; 1999 Mar; 12(1):23-9. PubMed ID: 10209061
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.
    Rees WA; Harkins JD; Lu M; Holland RE; Lehner AF; Tobin T; Chambers TM
    Am J Vet Res; 1999 Jul; 60(7):888-94. PubMed ID: 10407485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The suppression of cellular Na+/H+ exchange leads to the inhibition of influenza virus activity].
    Kirillov VA; Goreva LN; Vladyko GV; Boreko EI; Rusiaev VA; Votiakov VI
    Antibiot Khimioter; 1991 Jun; 36(6):35-7. PubMed ID: 1898187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deproteinization of influenza virus in the presence of rimantadine.
    Bubovich VI; Ryazantseva GM; Indulen MK
    Acta Virol; 1985 Mar; 29(2):104-10. PubMed ID: 2408452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.
    Bukrinskaya AG; Vorkunova NK; Pushkarskaya NL
    J Gen Virol; 1982 May; 60(Pt 1):61-6. PubMed ID: 7097251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virion transcriptase activity of rimantadine-sensitive and rimantadine-resistant variants of human influenza virus.
    Indulen MK; Kalninya VA; Gorodkova NV; Akopova II; Ghendon YuZ
    Acta Virol; 1987 Nov; 31(6):458-62. PubMed ID: 2894138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of remantadine and ribavirin on the production and antiviral action of human interferon types I and II].
    Nosik DN; Aspetov RD; Novokhatskiĭ AS
    Antibiotiki; 1982 Jan; 27(1):49-54. PubMed ID: 6174074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.